Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Ocata Therapeutics Inc (NASDAQ:OCAT)

3.84
Delayed Data
As of Aug 28
 +0.07 / +1.86%
Today’s Change
3.06
Today|||52-Week Range
12.73
-36.95%
Year-to-Date
No recent news for Ocata Therapeutics Inc.

Today’s Trading

Previous close3.77
Today’s open3.75
Day’s range3.52 - 3.96
Volume414,753
Average volume (3 months)498,679
Market cap$162.1M
Dividend yield--
Data as of 3:59pm ET, 08/28/2015

Growth & Valuation

Earnings growth (last year)-17.00%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-29.83%
P/E ratioNM
Price/Sales1,206.25
Price/Book--

Competitors

 Today’s
change
Today’s
% change
RDHLRedhill Biopharma Lt...-0.15-1.16%
BITIBiotie Therapies Oyj+0.14+0.86%
NEOTNeothetics Inc+0.04+0.34%
ABEOAbeona Therapeutics ...+0.12+2.55%
Data as of 3:59pm ET, 08/28/2015

Financials

Next reporting dateNovember 10, 2015
EPS forecast (this quarter)-$0.17
Annual revenue (last year)$157.9K
Annual profit (last year)-$34.7M
Net profit margin-22,010.42%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Paul K. Wotton
Chief Operating &
Financial Officer
Edward H. Myles
Corporate headquarters
Marlborough, Massachusetts

Forecasts

Partner Offers